Skip to content

Preventing HIV/Aids in Drug Abusing Youth

Preventing HIV/Aids in Tx-Resistant Drug-Abusing Youth

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00680719
Enrollment
111
Registered
2008-05-20
Start date
2004-06-30
Completion date
2013-06-30
Last updated
2014-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Keywords

substance abuse, HIV risk, Behavior and Mental Disorders, HIV Seronegativity

Brief summary

This project involves two studies focusing on the engagement and treatment of adolescents diagnosed with substance use disorders. Study 1 will evaluate a promising parent-based engagement intervention, Community Reinforcement Training, designed to facilitate the entry of resistant drug-abusing adolescents in treatment. The approach will be compared with an Engagement As Usual intervention condition. Study 2 involves a controlled clinical trial evaluating the efficacy of an HIV/AIDS prevention intervention embedded in family-based drug abuse treatment for reducing HIV/AIDS risk behaviors and substance use. Adolescents who are successfully engaged in treatment through Study 1 will be randomly assigned to receive either family therapy alone or family therapy with the integrated HIV/AIDS prevention intervention. Both studies are being conducted in Portland, Oregon.

Interventions

BEHAVIORALIBFT /HIV prevention

Integrated Behavioral and Family Therapy (IBGT) with HIV prevention.

BEHAVIORALIBFT

Integrated Behavioral and Family Therapy (IBFT).

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Oregon Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to 20 Years
Healthy volunteers
Yes

Inclusion criteria

* Parents have an adolescent in the ages of 15-20 years. * Have had contact with the adolescent on at least 40% of the past 90 days. * Have some knowledge or evidence that the adolescent would meet DSM-IV diagnostic criteria for a substance abuse disorder. * Adolescent has explicitly refused to attend any intake or therapy sessions. * All parents' efforts to enter adolescent into treatment have failed, despite therapist's assistance. * Residence in Portland vicinity. * Sufficient residential stability to permit probable contact at follow-up. (e.g. not homeless at time of intake)

Exclusion criteria

* Evidence of psychotic or organic state of sufficient severity to interfere with understanding of study instruments and procedures. * Adolescent has received residential drug treatment longer than a 2-week period in the past 90 days.

Design outcomes

Primary

MeasureTime frame
Changes in adolescent's substance use.12 months

Secondary

MeasureTime frame
Changes in HIV risk behaviors.12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026